docetaxel anhydrous has been researched along with Complication, Postoperative in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (12.50) | 29.6817 |
2010's | 12 (50.00) | 24.3611 |
2020's | 9 (37.50) | 2.80 |
Authors | Studies |
---|---|
Doki, Y; Kakeji, Y; Kawakubo, H; Kitagawa, Y; Matsuda, S; Muto, M; Okamura, A; Okui, J; Takemura, R; Takeuchi, H; Watanabe, M | 1 |
Fujiwara, T; Hashimoto, M; Katsui, K; Maeda, N; Nishizaki, M; Noma, K; Sakurama, K; Shirakawa, Y; Tanabe, S | 1 |
Chen, LF; Ji, ZH; Li, XB; Li, Y; Lin, YL; Ma, R; Yan, FC; Yang, ZR; Zhang, J | 1 |
Bateman, A; Byrne, JP; Grace, BL; Iveson, T; Jackson, A; Kelly, JJ; Noble, F; Pucher, PH; Rahman, SA; Rees, C; Underwood, TJ; Walker, RC | 1 |
Arakawa, Y; Matsumoto, A; Mitsumori, N; Nishikawa, K; Tanaka, Y; Tanishima, Y; Yanaga, K; Yuda, M | 1 |
Doki, Y; Eguchi, H; Fujitani, K; Hirao, M; Kimura, Y; Makino, T; Miyata, H; Mori, M; Motoori, M; Shiraishi, O; Sugimura, K; Takeno, A; Tanaka, K; Yamasaki, M; Yano, M; Yasuda, T | 1 |
Li, C; Li, J; Liu, B; Liu, W; Ma, T; Sah, BK; Shi, M; Xu, W; Yan, C; Yan, M; Yuan, F; Zhang, B; Zhang, H; Zhu, Z | 1 |
Aoyama, T; Atsumi, Y; Cho, H; Kano, K; Kazama, K; Maezawa, Y; Masuda, M; Murakami, H; Numata, M; Oshima, T; Rino, Y; Saeki, H; Sato, T; Tamagawa, H; Tsuchida, K; Yamada, T; Yamamoto, Y; Yukawa, N | 1 |
Gęca, K; Małecka-Massalska, T; Mlak, R; Pelc, Z; Polkowski, WP; Rawicz-Pruszyński, K; Sędłak, K; Skórzewska, M | 1 |
Boito, R; Bova, F; Colombo, AF; Greco, S; Lucà, R; Rizzuto, G; Sellaro, A | 1 |
Bu, JH; Bu, QA; Cui, T; You, FP; Yuan, QZ | 1 |
Barone, M; Basilico, R; Carella, C; Colasante, A; De Tursi, M; Filippone, A; Guetti, L; Mani, A; Massari, R | 1 |
Blohmer, JU; Eggemann, H; Eidtmann, H; Fasching, P; Gerber, B; Hanusch, C; Hauschild, M; Huober, J; Jackisch, C; Kittel, K; Kunz, G; Loibl, S; Nekljudova, V; Rezai, M; Schrader, I; Solbach, C; Tesch, H; Untch, M; von Minckwitz, G | 1 |
Baba, H; Baba, Y; Ida, S; Imamura, Y; Ishimoto, T; Iwagami, S; Karashima, R; Miyamoto, Y; Sakamoto, Y; Watanabe, M; Yoshida, N | 1 |
Hoelen, W; Hugenholtz-Wamsteker, W; Meeus, M; Nijs, J; Robbeson, C | 1 |
Benatar-Haserfaty, J; Durán Paz, S; Moreno Casanova, I | 1 |
Doki, Y; Fujitani, K; Hirao, M; Kimura, Y; Kobayashi, K; Makino, T; Miyata, H; Motoori, M; Shinkai, M; Shiraishi, O; Tamura, S; Yamasaki, M; Yano, M; Yasuda, T | 1 |
Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Okada, K; Takiguchi, S; Yamasaki, M | 1 |
Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Takiguchi, S; Yamasaki, M | 1 |
Abe, T; Hatooka, S; Kondo, C; Mizota, A; Muro, K; Nomura, M; Shinoda, M; Shitara, K; Takahari, D; Ura, T; Yatabe, Y; Yokota, T | 1 |
Fujimura, T; Fujita, H; Fushida, S; Hayashi, H; Kinoshita, J; Kitagawa, H; Makino, I; Nakagawara, H; Nakamura, K; Ninomiya, I; Ohta, T; Oyama, K; Tajima, H; Takamura, H; Tani, T | 1 |
Aoe, M; Date, H; Fujiwara, T; Hiraki, Y; Katayama, H; Kiura, K; Kozuki, T; Shimizu, N; Tabata, M; Takemoto, M; Tanaka, N; Tanimoto, M; Ueoka, H | 1 |
Dempsey, DT; Furukawa, S; Gupta, D; McClurken, JB; Piacentino, V; Ross, K; Stepnowski, D | 1 |
Hiraga, K; Honda, O; Matsuo, K | 1 |
2 review(s) available for docetaxel anhydrous and Complication, Postoperative
Article | Year |
---|---|
The effect of docetaxel on developing oedema in patients with breast cancer: a systematic review.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Edema; Female; Humans; Lymphedema; Mastectomy; Postoperative Complications; Risk Factors; Taxoids | 2016 |
[Posterior reversible encephalopathy syndrome after neurosurgery: A literature review].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Blindness, Cortical; Brain Neoplasms; Craniotomy; Docetaxel; Epilepsy, Tonic-Clonic; Frontal Lobe; Humans; Hypertension; Male; Middle Aged; Paresis; Posterior Leukoencephalopathy Syndrome; Postoperative Complications; Prednisone; Prostatic Neoplasms; Taxoids | 2015 |
5 trial(s) available for docetaxel anhydrous and Complication, Postoperative
Article | Year |
---|---|
Multicenter Randomized Phase 2 Trial Comparing Chemoradiotherapy and Docetaxel Plus 5-Fluorouracil and Cisplatin Chemotherapy as Initial Induction Therapy for Subsequent Conversion Surgery in Patients With Clinical T4b Esophageal Cancer: Short-term Result
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Fluorouracil; Humans; Induction Chemotherapy; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Postoperative Complications; Prospective Studies | 2021 |
Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; China; Docetaxel; Female; Fluorouracil; Gastrectomy; Humans; Leucovorin; Male; Middle Aged; Morbidity; Neoadjuvant Therapy; Oxaliplatin; Patients; Postoperative Complications; Stomach; Stomach Neoplasms; Treatment Outcome | 2020 |
Short-term results of a phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Postoperative Complications; Preoperative Care; Stomach Neoplasms; Tegafur; Time Factors | 2021 |
Observation and analysis of clinical efficacy of breast-conserving therapy integrated with neoadjuvant chemotherapy on Breast Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; China; Docetaxel; Epirubicin; Female; Humans; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Postoperative Complications; Quality of Life; Recurrence; Survival Analysis; Treatment Outcome | 2018 |
Surgical outcome after neoadjuvant chemotherapy and bevacizumab: results from the GeparQuinto study (GBG 44).
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Epirubicin; Female; Follow-Up Studies; Humans; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Postoperative Complications; Prognosis; Prospective Studies; Taxoids; Young Adult | 2014 |
17 other study(ies) available for docetaxel anhydrous and Complication, Postoperative
Article | Year |
---|---|
Old age and intense chemotherapy exacerbate negative prognostic impact of postoperative complication on survival in patients with esophageal cancer who received neoadjuvant therapy: a nationwide study from 85 Japanese esophageal centers.
Topics: Aged; Anastomotic Leak; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; East Asian People; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Neoadjuvant Therapy; Pneumonia; Postoperative Complications; Prognosis; Retrospective Studies | 2023 |
Induction chemoradiotherapy including docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer.
Topics: Aged; Anastomotic Leak; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagectomy; Febrile Neutropenia; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Invasiveness; Postoperative Complications; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vocal Cord Paralysis | 2020 |
Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Blood Loss, Surgical; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Erythrocyte Transfusion; Female; Humans; Hyperthermia, Induced; Intestinal Fistula; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Postoperative Complications; Postoperative Hemorrhage; Pseudomyxoma Peritonei; Retrospective Studies; Risk Factors; Young Adult | 2020 |
Outcomes and survival following neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus: Inverse propensity score weighted analysis.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Disease-Free Survival; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Hospital Mortality; Humans; Length of Stay; Leucovorin; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxaliplatin; Postoperative Complications; Propensity Score; Survival Rate; Treatment Outcome | 2020 |
Five-year Outcomes of Chemotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Oesophagectomy in Oesophageal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Japan; Lymphatic Metastasis; Male; Middle Aged; Postoperative Complications; Prognosis; Treatment Outcome | 2020 |
Union is strength: Textbook outcome with perioperative chemotherapy compliance decreases the risk of death in advanced gastric cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Docetaxel; Epirubicin; Female; Fluorouracil; Gastrectomy; Guideline Adherence; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Outcome and Process Assessment, Health Care; Oxaliplatin; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Stomach Neoplasms; Survival Rate | 2022 |
[Atypical Hemolitic Uremic Syndrome after administration of Docetaxel].
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Atypical Hemolytic Uremic Syndrome; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Humans; Lymph Node Excision; Male; Middle Aged; Penile Neoplasms; Plasma; Postoperative Complications; Renal Dialysis; Taxoids | 2018 |
Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Doxorubicin; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Kaplan-Meier Estimate; Laparotomy; Length of Stay; Middle Aged; Neoadjuvant Therapy; Omentum; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Polyethylene Glycols; Postoperative Complications; Recurrence; Taxoids; Treatment Outcome | 2014 |
Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Body Composition; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Postoperative Complications; Prognosis; Survival Rate; Taxoids | 2014 |
Feasibility of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal Cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Doxorubicin; Esophageal Neoplasms; Feasibility Studies; Female; Fluorouracil; Humans; Male; Middle Aged; Postoperative Complications; Taxoids | 2017 |
Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Postoperative Complications; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids | 2011 |
Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Peritoneal Neoplasms; Postoperative Complications; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome | 2012 |
Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Postoperative Complications; Recurrence; Retrospective Studies; Taxoids; Treatment Outcome | 2011 |
Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Oxonic Acid; Postoperative Complications; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur | 2012 |
Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Docetaxel; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pleural Effusion; Postoperative Complications; Preoperative Care; Survival Rate; Taxoids | 2004 |
Use of LeVeen pleuroperitoneal shunt for refractory high-volume chylothorax.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chylothorax; Cisplatin; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagectomy; Fatal Outcome; Fluorouracil; Humans; Ligation; Male; Middle Aged; Neoplasm Metastasis; Parenteral Nutrition, Total; Peritoneovenous Shunt; Pleural Effusion; Postoperative Complications; Respiration, Artificial; Taxoids; Thoracostomy; Thoracotomy; Tissue Adhesives | 2004 |
[Cardiac conduction abnormalities after neoadjuvant chemotherapy with doxorubicin and docetaxel for primary breast carcinoma: a case report].
Topics: Aged; Anesthesia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Doxorubicin; Female; Heart Block; Humans; Intraoperative Complications; Mastectomy, Segmental; Paclitaxel; Postoperative Complications; Taxoids | 2001 |